Clinical TrialID 8457
Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen
NCT06048107
HLH
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8457
- Evidence Id
- 8457
- Core Evidence Id
- 8457
- Source Clinical Trial Id
- 8455
- Herb2 Clinical Trial Id
- HBCT008455
- Nct Id
- NCT06048107
- Title
- Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen
- Status
- Recruiting
- Phase
- Study Result
- No
- Study Condition
- HLH
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Teniposide
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 20
- Outcome Measure
- The clinical remission rate, The number of cases with complete response (CR) and partial response (PR) after ransplantation as a percentage of the total cases., 24 weeks
- Sponsor Collaborator
- Beijing Friendship Hospital
- Funded By
- OTHER
- Location
- Zhao Wang, Beijing, 100050, China, China
- Other Id
- BFH20230727002/BFHHZS20230169
- Start Date
- 2023-10-22
- Primary Completion Date
- 2024-09-30
- Completion Date
- 2025-09-30
- First Posted
- 2023-09-21
- Results First Posted
- Last Update Posted
- 2023-11-02
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT06048107
- Title Cn
- Title En
- Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen
- Bilingual Status
- semi_complete